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Abstract
Background: Polycystic ovary syndrome (PCOS) is a common female endocrine disorder of heterogeneous clinical
presentation, high disease burden, and unknown aetiology. The disease and associated conditions cluster in families,
suggesting that PCOS may be the reproductive consequence of underlying chronic disease susceptibility.
Objective: To determine whether parents of young women with PCOS were more likely to have a history of diabetes or
cardiovascular disease in later adult life.
Design, Setting and Participants: Structured interviews with 715 members of a cohort constructed by tracing female
infants born at a single general hospital in Adelaide between 1973 and 1975. Participants were asked whether they had a
pre-existing medical diagnosis of PCOS, and whether each parent had ever had high blood pressure, high cholesterol,
diabetes, stroke, or heart disease. Maternal high blood pressure during pregnancy was taken from the medical record of the
pregnancy with the study participant.
Results and Conclusions: Mothers of women with PCOS were more likely than mothers of other women to have any
cardiovascular disease (RR 1.78, 95% CI 1.29, 2.47), and nearly twice as likely to have high blood pressure (RR 1.95, 95% CI
1.38, 2.76). Fathers of women with PCOS were more than twice as likely to have heart disease (RR 2.36, 95% CI 1.44, 3.88)
and over four times as likely to have had a stroke (RR 4.37, 95% CI 1.97, 9.70). Occurrence of cardiovascular disease in both
mother and father are associated with the risk of PCOS in daughters. Further detailed study is required to elucidate the
precise pathways that may be causally related to the observations.
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Introduction
Polycystic ovary syndrome (PCOS) is one of the most common
endocrine disorders in women, affecting between 8 and 18% of the
female population, depending on the diagnostic criteria used [1]. It
has a heterogeneous clinical presentation including menstrual
dysfunction, high androgen levels and evidence of multiple cysts
within the ovary on ultrasound. The burden of disease is high, with
complications including anovulatory infertility, endometrial can-
cer, hyperlipidemia, obesity and non-insulin dependent diabetes
mellitus (NIDDM) [2]. Gestational diabetes appears to be common
independent of prepregnancy weight and pregnancy weight gain
[3,4,5]. The annual cost of evaluating and treating the disorder in
the United States has been estimated at $4.36B (2005 USD) [6].
The aetiology of PCOS is unknown, although both genetic and
intra-uterine factors, such as androgen exposure during fetal develop-
ment, have been proposed [7]. There is evidence of clustering of the
condition within families [8], although examination of data from
twins does not support a simple pattern of inheritance [9]. There is
also evidence of clustering for related chronic disease entities,
including diabetes mellitus [10,11] and cardiovascular disease risk
[2,12,13,14], within families in which PCOS is represented. This
raisesthequestion asto whetherPCOSmaybe re-conceptualised as
the reproductive consequences of underlying chronic disease
susceptibility that is clustered within families. There is limited data
on this matter, as there are few long-term follow-up studies of
women with PCOS to examine disease progression, and none that
have sought to compile detailed family histories within a population
based sample.
The aim of the present study was to determine whether parents
of women with an existing diagnosis of PCOS were more likely
than other parents to have a history of diabetes or cardiovascular
disease in later adult life.
Methods
Participants
As described elsewhere [1], the present cohort was built by
tracing women born at the Queen Elizabeth Hospital (QEH)
between 1973 and 1975. Daughters were initially traced after
locating and contacting their mothers. If unsuccessful, attempts
were then made to contact the daughter by other means, such as
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(93.0%) daughters were traced, of whom 62 were deceased or
disabled (3.0%), leaving 1984 (90.2%) women invited to participate
in the study. Of these, 945 (47.6%) agreed to participate; of these,
715 were resident in Adelaide and thus eligible for the current
analysis.Of those, twenty-two wereestrangedfrom their fathers and
four from their mothers, and hadno medical information about that
parent. Estranged parents were excluded from analyses. There were
no differences in birth outcomes between participants and non-
participants. With regard to parents, and their daughters, the only
evidence of difference between participants and non-participants
was the slight over-representation of residents from the least socio-
economically deprived suburbs [1].
Study Protocol
Interviews were conducted by trained research nurses, usually in
the home of the participant. A medical history was obtained,
focusing on gynaecological history. The study was approved by the
Central Northern Adelaide Health Service Ethics of Human
Research Committee and The University of Adelaide Human
Research Ethics Committee, and all participants gave written
informed consent.
PCOS status was ascertained by participants’ report of a pre-
existing medical diagnosis. As women who had remained in
Adelaide had greater access to specialists for diagnosis of PCOS
than those who had moved elsewhere in the state, analyses
presented in the current paper were limited to Adelaide residents.
Analyses performed with all women were consistent with those
limited to Adelaide residents. Parental illness was determined by
asking participants whether each parent had ever had a medical
history of high blood pressure, high cholesterol, diabetes, stroke, or
heart disease. If a parent had ever had high blood pressure, stroke,
or heart disease, he or she was classed as having had ‘‘any
cardiovascular disease’’. The date for the diagnosis of the conditions
was not recorded. Maternal high blood pressure during pregnancy
was taken from the medical record of the pregnancy with the study
participant, and was defined as ever having had a visit with a
recorded diastolic blood pressure in excess of 89 mmHg. Oral
glucose tolerance testing in pregnancy was not performed routinely
in the 1970s and was therefore unavailable for the present analysis
to assess gestational diabetes.
Statistical analysis
We used multivariate log-binomial regression to generate
relative risks with daughter PCOS as the independent variable.
Each parental condition became a dependent variable in separate
regression models. Socioeconomic status (SES) was included in all
models as potential confounders. The SES measure used was the
Australian Bureau of Statistics Socioeconomic Indexes for Areas
(SEIFA) quartile of disadvantage for the postal code of the family’s
residence at the time of the daughter’s birth [15]. Parental age was
not considered as a potential confounder. While associated with
the outcomes of interest, we do not known of an association of
parental age at delivery and risk of PCOS in daughters. Moreover,
inclusion of parent age as a confounder in the analysis would not
be appropriate if parental age was in the causal pathway. This
would occur if there is an association between risk of chronic
disease and age at delivery, which is plausible in the case of
maternal history of diabetes.
Models used log-binomial rather than logistic regression
because where outcomes are common in a study population
(.5%), as with some parental conditions considered, odds ratios
may underestimate relative risk (for a discussion, see [16]). Missing
values for maternal smoking during pregnancy (n=41), maternal
high blood pressure during pregnancy (n=283), maternal disease
status (n=24) and paternal disease status (n=100) were multiply
imputed using regression models, with 100 imputations. Sensitivity
analyses were performed by varying the multiply imputed models.
The results from the sensitivity analyses were similar to those
presented in this paper.
A P value of ,0.05 for the Wald test on the adjusted estimate of
interest was considered statistically significant. All statistical
analyses were carried out using SASH software, Version 9.2 of
the SAS System for Windows. (2009 SAS Institute Inc., Cary, NC,
USA.)
Results
Among women residing in Adelaide, 41 (5.7%) reported an
existing diagnosis of PCOS (Table 1). Nearly all mothers survived
to the time of interview, as did most fathers.
Table 2 shows relationships between parental chronic disease
status and daughter’s PCOS. Mothers of women with PCOS were
more likely than other mothers to have a daughter report of any
cardiovascular disease (adjusted relative risk (RR) 1.78 (95%
confidence interval (CI) 1.29, 2.47), and were nearly twice as likely
to have high blood pressure (RR 1.95, 95% CI 1.38, 2.76).
Mothers of women with PCOS were also more likely to have had
high blood pressure during pregnancy (RR 1.49, 95% CI 0.97,
2.30), although this relationship did not reach statistical signifi-
cance. There was no statistically significant relationship between
daughter’s PCOS and reported maternal hypercholesterolemia,
diabetes, heart disease or stroke.
Fathers of women with PCOS were more than twice as likely to
have a report of heart disease (RR 2.36, 95% CI 1.44, 3.88) and
over four times as likely to have had a stroke (RR 4.37, 95% CI
1.97, 9.70. Among fathers, there was no significant relationship
between reported hypercholesterolemia, diabetes or high blood
pressure and daughter’s PCOS.
Findings were unchanged by adjustment for socioeconomic
status. Secondary analyses with all participants were consistent
with the present findings, as were sensitivity analyses.
Discussion
In this family history study, we confirmed previous associations
indicating that the parents of women who had been diagnosed
with PCOS were more subject to chronic diseases than parents of
women who had never been diagnosed with PCOS [17].
Specifically, high blood pressure in mothers was nearly twice as
frequent if a daughter had PCOS. This finding was consistent
with, and more robust than, the association between mother’s
elevated blood pressure during pregnancy as obtained from the
maternity record and daughter’s PCOS. In addition, the relative
risks for heart disease, diabetes and stroke were also elevated but
not significant.
Interestingly, the pattern of maternal disease was replicated, in
part, in the father’s history, with particularly robust associations
for stroke and heart disease. Again, the associations with parental
history of diabetes were elevated but the wide confidence intervals
precluded directly replicating the findings reported previously
[11].
This study varied from those reported previously as it is a
community based cohort using a defined sampling frame, rather
than a convenience sample from clinics. Most other studies used
infertility or gynaecology clinic samples as the source of both
PCOS and comparison populations, which is problematic as the
population of probands with infertility problems might reasonably
be expected to have higher proportions of both sex hormone and
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producing a comparison family population more similar to the
PCOS families than a general population of families. This results
in both underestimation of associations and loss of generalizability.
The attenuation of measures of association may account for some
of the inconsistent findings in previous family studies.
Our participation rate was high, given the 30+ years elapsed
before tracing, and showed little evidence of participation bias [1];
the study also used trained nurse-interviewers. However, it did not
include direct assessment of disease status in either daughter or
parents, except for the use of hospital records to ascertain maternal
high blood pressure in pregnancy.
Nevertheless, there is merit in these proxy reports on disease
experience as it has been demonstrated previously [18] that CHD
family history can be captured effectively with accuracy over 80%.
The additional imprecision from recall and reporting, and limited
sample sizewithinthe outcome groups is likely to have increased the
confidence intervals observed here, which may explain why a
number of the associations did not achieve statistical significance.
We therefore do not preclude other potential associations, including
the observed family history of diabetes in both mother and father.
Further, while the study relied upon daughter’s reports of parental
disease history, the consistency of effect for maternal high blood
pressure from daughter reports and independent maternity records
suggests that the reports are not spurious. Similarly, if reporting bias
were the major contributor to the findings, then one would expect
strong and specific associations for a family history of diabetes,
which has a well-established association with PCOS.
Replication of these observations in other cohorts is warranted,
as is detailed clinical examination of the surviving parents, which
was beyond the scope of the current project that focussed primarily
on reproductive experiences of young women.
Parent-of-origin effects have been noted previously for CVD
risk in fathers, including incident stroke, and metabolic perturba-
tions in offspring [12,19]. For example, in a case-control study of
PCOS Moini observed that a maternal family history of diabetes
was not associated with PCOS, in contrast to a paternal family
history of heart attack and thrombosis. [19].
The association between paternal stroke and PCOS may be
associated with some direct mechanism, or mediated through a
factor(s) associated both with stroke and PCOS risk. Obesity is one
such factor, as paternal obesity has been associated with PCOS
[20].Thisis ofpotentialinterestasrecent experimentalobservations
in a rodent model reveal that paternal high fat diet and increased
Table 1. Demographic characteristics of parents of young women.
Mother of PCOS
daughter (n=41)
Number (%)
Mother of unaffected
daughter (n=674)
Number (%)
Father of PCOS
daughter (n=41)
Number (%)
Father of unaffected
daughter (n=674)
Number (%)
Parents living at time of interview n (%) 40 (97.6) 648 (96.1) 38 (92.7) 597 (90.7)
Mother’s age at time of interview, median,
midquartile range (years)
52, 49–56 54, 51–58 –
Parents known to be estranged n (%) 0 (0.0) 4 (0.6) 0 (0.0) 22 (3.4)
Household SEIFA at birth (median,
midquartile range)
975.8 873.9–1033.7 947.0 893.3–1008.5 975.8 873.9–1033.7 947.0 893.3–1008.5
Mother’s country of birth n (%)
Australia 28 (68.3) 405 (60.1) – –
United Kingdom 4 (9.8) 69 (10.2) – –
Other Northwest Europe 1 (2.4) 28 (4.2) – –
Southeast Europe 8 (19.5) 158 (23.4) – –
Other 0 14 (2.1) – –
Education n (%)
Some primary school 3 (7.3) 49 (7.3) 4 (9.8) 67 (10.0)
Completed primary school 1 (2.4) 42 (6.2) 0 (0.0) 41 (6.1)
Some high school 24 (58.5) 276 (41.0) 14 (34.1) 169 (25.1)
Completed high school 3 (7.3) 75 (11.1) 2 (4.9) 43 (6.4)
Trade school/non-university 7 (17.1) 150 (22.2) 13 (31.7) 213 (31.7)
Any university 2 (4.9) 40 (5.9) 4 (9.8) 42 (6.3)
Don’t know 1 (2.4) 41 (6.1) 4 (9.8) 97 (14.4)
Smoked while pregnant n (%) 7 (18.9) 156 (24.5)
Parity n (%)
0 20 (48.8) 285 (42.3)
1 12 (29.3) 220 (32.6)
2 5 (12.2) 112 (16.6)
3+ 4 (9.8) 57 (8.4)
Mother’s age at delivery median, midquartile
range (years)
22, 19–26 24, 21–28
PCOS: Polycystic ovary syndrome; SEIFA: Socioeconomic Indexes for Areas.
doi:10.1371/journal.pone.0025947.t001
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female offspring with features of impaired insulin secretion and
glucose tolerance that worsened with time [21]. Further, the
demonstration that paternal high fat diet altered the expression of
pancreatic islet genes in adult female offspring provides evidence of
biological plausibility for non-genetic, intergenerational transmis-
sion of metabolic features from father to daughter.
In conclusion, these findings highlight the presence of robust
associations at an observational level that invoke a range of
biologically plausible mechanisms and indicate a need for further
detailed clinical investigation in both parents and child.
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Table 2. Relationships between parental health condition and PCOS in young women.
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1 (95% CI) Adjusted RR
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Mother 41 (100.0) 674 (100.0) – –
High blood pressure 20 (48.8) 172 (25.5) 1.91 (1.36, 2.69) 1.95 (1.38, 2.76)
High cholesterol 8 (19.5) 139 (20.6) 0.95 (0.50, 1.80) 0.92 (0.48, 1.76)
Diabetes 5 (12.2) 64 (9.6) 1.28 (0.54, 3.00) 1.37 (0.58, 3.22)
Stroke 2 (4.9) 25 (3.7) 1.31 (0.32, 5.36) 1.27 (0.30, 5.31)
Heart disease 4 (9.8) 31 (4.6) 2.13 (0.79, 5.78) 2.07 (0.76, 5.60)
High blood pressure during pregnancy 18 (44.9) 204 (30.3) 1.47 (0.96, 2.27) 1.49 (0.97, 2.30)
Any cardiovascular disease
3 21 (51.2) 196 (29.1) 1.76 (1.28, 2.43) 1.78 (1.29, 2.47)
Father 41 (100.0) 674 (100.0)
High blood pressure 11 (26.5) 200 (29.7) 0.89 (0.51, 1.54) 0.90 (0.52, 1.55)
High cholesterol 15 (36.1) 219 (39.2) 1.11 (0.71, 1.74) 1.10 (0.70, 1.72)
Diabetes 8 (19.5) 106 (15.7) 1.26 (0.64, 2.51) 1.28 (0.65, 2.53)
Stroke 8 (19.5) 28 (4.2) 4.45 (1.97, 10.01) 4.37 (1.97, 9.70)
Heart disease 14 (13.2) 101 (15.0) 2.27 (1.38, 3.74) 2.36 (1.44, 3.88)
Any cardiovascular disease
3 20 (48.8) 264 (39.2) 1.24 (0.88, 1.76) 1.29 (0.88, 1.96)
PCOS: polycystic ovary syndrome; RR: relative risk; CI: confidence interval. Sig. associations in bold.
1Combined results of multiply imputed models.
2Adjusted for SEIFA at birth. Combined results of 11 multiply imputed models.
3Any cardiovascular disease: high blood pressure, stroke or heart disease.
doi:10.1371/journal.pone.0025947.t002
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